A detailed history of Stonebrook Private Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Stonebrook Private Inc. holds 4,902 shares of DXCM stock, worth $365,002. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,902
Previous 4,402 11.36%
Holding current value
$365,002
Previous $499 Million 34.16%
% of portfolio
0.09%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $32,000 - $58,030
500 Added 11.36%
4,902 $329 Million
Q2 2024

Aug 06, 2024

BUY
$110.31 - $140.45 $239,924 - $305,478
2,175 Added 97.67%
4,402 $499 Million
Q1 2024

May 07, 2024

BUY
$114.22 - $140.1 $254,367 - $312,002
2,227 New
2,227 $309 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Stonebrook Private Inc. Portfolio

Follow Stonebrook Private Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebrook Private Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stonebrook Private Inc. with notifications on news.